Chain-of-thought monitorability could improve generative AI safety by assessing how models come to their conclusions and ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

OpenAI and Google's AI models achieved impressive results in a difficult math competition, but disputed how the other got ...

The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter human trials with a drug candidate designed using artificial ...

After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...

Alphabet's Google and OpenAI said their artificial-intelligence models won gold medals at a global mathematics competition, ...

An artificial intelligence system built by Google DeepMind, the tech giant’s primary artificial intelligence lab, has ...

Google DeepMind subsidiary, Isomorphic Labs, has said it is ready to conduct human trials for drugs developed using its AlphaFold AI technology.

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...